XERS Cash & Equivalents
Xeris Biopharma Holdings Inc · Cash & Equivalents
XERS Cash & Equivalents
Latest reported$111.04Mperiod ending
XERS FY Cash & Equivalents ($32.27M → $111.04M)
Annual Cash & Equivalents
High-resolution chart · PNG
XERS cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 111,042,000 | |
| 71,621,000 | |
| 67,449,000 | |
| 121,966,000 | |
| 67,271,000 | |
| 37,598,000 | |
| 19,519,000 | |
| 45,716,000 | |
| 42,045,000 | |
| 32,269,000 |